# Chrysalis Biotherapeutics, Inc.

Canonical: https://abierto.us/vendors/chrysalis-biotherapeutics-inc-xw1vfggrldw3

- UEI: XW1VFGGRLDW3
- CAGE: 5DAY4
- Location: Galveston, TX
- Awards in window: 1 (1 transactions), -$11,857,903 obligated, July 25, 2025 to July 25, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, -$11,857,903

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): -$11,857,903

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50119C00016 (definitive contract): -$11,857,903, Barda - Aspr / Daappo / Barda DCMA. De-Obligate Remaining Funds and Closeout the Contract in Its Entirety.. https://www.usaspending.gov/award/CONT_AWD_75A50119C00016_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/chrysalis-biotherapeutics-inc-xw1vfggrldw3.